EPISODE 027
After five years and $25 million, Vascular Solutions CEO Howard Root watched a jury confirm what he knew all along. His company had done nothing wrong. In this interview, Root and Mark Duval, who is advising companies in this area but didn’t work with Vascular Solutions, explain what all this means for Medtech executives.
Podcast Guest
Howard Root
Retired CEO
Vascular Solutions
Howard Root is the retired Chief Executive Officer of Vascular Solutions, Inc., a company he founded in 1997, took public in 2000 and grew into a worldwide medical device company that he sold to Teleflex in February 2017 for $1 billion. Over the company’s 20 years, Howard led Vascular Solutions in inventing, developing and launching over 100 new medical devices used to improve the lives of patients suffering from cardiovascular disease. The motivation behind the sale of Vascular Solutions and Howard’s voluntary early retirement is a true-life legal nightmare that is detailed in Howard’s book: Cardiac Arrest: Five Heart-Stopping Years as a CEO on the Feds’ Hit-List.
Meet Our Host
Geoff Pardo
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.